順天堂大学医学部附属順天堂医院は、東京都文京区本郷3-1-3にある医療機関。学校法人順天堂が運営する病院であるが、診療所の名称として用いられることの多い「医院」という呼称を開院以来一貫して用いている。特定機能病院の承認を受けている。外来患者数は2019年3末迄の1年間に1日平均4459人。

During the past decade, Juntendo University Hospital conducted 80 clinical trials. In the 10-year time frame, 80 clinical trials started and 21 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 15 clinical trials were completed. i.e. 25.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Juntendo University Hospital" #1 sponsor was "Eli Lilly and Company" with 15 trials, followed by "Pfizer" with 11 trials sponsored, "Takeda" with 11 trials sponsored, "Janssen Research & Development, LLC" with 10 trials sponsored and "Amgen" with 10 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Juntendo University Hospital" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Juntendo University Hospital" are "Ulcerative Colitis" (8 trials), "Colitis, Ulcerative" (4 trials), "Crohn's Disease" (4 trials), "Breast Neoplasms" (3 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Juntendo University Hospital" in a lesser frequency.

Most popular intervention types in "Juntendo University Hospital" are "Drug" (80 trials), "Biological" (5 trials), "Other" (5 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Mirikizumab" (4 trials), "Ustekinumab" (4 trials), "Abemaciclib" (3 trials) and "Baricitinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Juntendo University Hospital" are 87 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Juntendo University Hospital". undefined are not yet recruiting, 38 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Juntendo University Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Juntendo University Hospital, 3 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".